Stay updated on Safety Tolerance Efficacy in IPF Clinical Trial

Sign up to get notified when there's something new on the Safety Tolerance Efficacy in IPF Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety Tolerance Efficacy in IPF Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The record now presents details of the completed Phase 2 idiopathic pulmonary fibrosis study, including its treatment arms, eligibility criteria, study locations, outcomes, and related publications.
    Difference
    50%
    Check dated 2026-11-07T13:48:01.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0; the study page still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T14:33:08.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a terminology transition from “Artificial Intelligence” to “Super Intelligence.” It appears above the 403 error page instead of study details.
    Difference
    1%
    Check dated 2026-10-24T15:57:29.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T15:50:50.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision changes from v3.7.0 to v3.7.1; the page continues to show an access-denied error.
    Difference
    0.2%
    Check dated 2026-10-10T15:47:54.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record content, effectively blocking access to the study details.
    Difference
    17%
    Check dated 2026-09-19T19:08:11.000Z thumbnail image

Stay in the know with updates to Safety Tolerance Efficacy in IPF Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety Tolerance Efficacy in IPF Clinical Trial page.